Revolutionizing cancer treatment
with precision-designed oncolytic viral therapies
Harnessing the power of synthetic biology
we engineer cancer killing viruses
Our platform
Our state-of-the-art platform is specifically developed to expedite the design and testing of
oncolytic viral therapies.
![](/wp-content/uploads/2023/08/platform-rvn1.jpg)
Computer-Aided Design
Our software enables the freedom to design complex structures and the reuse of existing and proven building blocks
![](/wp-content/uploads/2023/08/platform-rvn2.jpg)
DNA synthesis
Sequence perfect DNA enables our high quality pipeline
![](/wp-content/uploads/2023/08/platform-rvn3.jpg)
Cell transfection and virus testing
We assemble the DNA fragments into complete genomes, transfect cells and make the viruses
Our products
Our cancer therapies have the following characteristics:
- Unparalleled safety – using selective infection and selective replication
- Maximize therapeutic window – no seroprevalence
- Highly lytic – ensuring efficient killing of cancer cells
- Systematic delivery – to treat primary tumor and metastases
- Cost-effective production – designed with manufacturing in mind